4.8 Article

Antibody landscapes after influenza virus infection or vaccination

Journal

SCIENCE
Volume 346, Issue 6212, Pages 996-1000

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1256427

Keywords

-

Funding

  1. Medical Research Council Fellowship [MR/K021885/1]
  2. Homerton College
  3. Gates-Cambridge Scholarship
  4. NIH Oxford-Cambridge Scholars program
  5. Royal Society University Research Fellowship [RG55423]
  6. National Institute of Allergy and Infectious Diseases-NIH Centers of Excellence for Influenza Research and Surveillance contracts [HHSN266200700010C, HHSN272201400008C]
  7. Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant [91896613]
  8. European Union [223498, 278976]
  9. Human Frontier Science Program grant [P0050/2008]
  10. Wellcome Trust [WT087982MA]
  11. NIH Director's Pioneer Award [DP1-OD000490-01]
  12. Australian government Department of Health
  13. Medical Research Council [MR/K021885/1] Funding Source: researchfish
  14. MRC [MR/K021885/1] Funding Source: UKRI

Ask authors/readers for more resources

We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available